These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers. Liu Q, Liang J, Zhou D, Krauss DJ, Chen PY, Yan D. Int J Radiat Oncol Biol Phys; 2018 Jul 15; 101(4):985-997. PubMed ID: 29976511 [Abstract] [Full Text] [Related]
3. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors. Henke LE, Kashani R, Hilliard J, DeWees TA, Curcuru A, Przybysz D, Green O, Robinson CG, Bradley JD. Int J Radiat Oncol Biol Phys; 2018 Nov 15; 102(4):987-995. PubMed ID: 29953910 [Abstract] [Full Text] [Related]
4. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer. Bohoudi O, Bruynzeel AME, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ, Palacios MA. Radiother Oncol; 2017 Dec 15; 125(3):439-444. PubMed ID: 28811038 [Abstract] [Full Text] [Related]
10. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen. Henke L, Kashani R, Robinson C, Curcuru A, DeWees T, Bradley J, Green O, Michalski J, Mutic S, Parikh P, Olsen J. Radiother Oncol; 2018 Mar 27; 126(3):519-526. PubMed ID: 29277446 [Abstract] [Full Text] [Related]
11. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer. Da Silva Mendes V, Nierer L, Li M, Corradini S, Reiner M, Kamp F, Niyazi M, Kurz C, Landry G, Belka C. Radiat Oncol; 2021 Jul 21; 16(1):133. PubMed ID: 34289868 [Abstract] [Full Text] [Related]
12. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer. El-Bared N, Portelance L, Spieler BO, Kwon D, Padgett KR, Brown KM, Mellon EA. Pract Radiat Oncol; 2019 Jan 21; 9(1):e46-e54. PubMed ID: 30149192 [Abstract] [Full Text] [Related]
13. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors. Finazzi T, Palacios MA, Spoelstra FOB, Haasbeek CJA, Bruynzeel AME, Slotman BJ, Lagerwaard FJ, Senan S. Int J Radiat Oncol Biol Phys; 2019 Jul 15; 104(4):933-941. PubMed ID: 30928360 [Abstract] [Full Text] [Related]
18. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers. Padgett KR, Simpson G, Asher D, Portelance L, Bossart E, Dogan N. Phys Med; 2020 Sep 15; 77():54-63. PubMed ID: 32781388 [Abstract] [Full Text] [Related]
19. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy. Taylor E, Lukovic J, Velec M, Shessel A, Stanescu T, Dawson L, Létourneau D, Lindsay P. Acta Oncol; 2021 Feb 15; 60(2):260-266. PubMed ID: 33170058 [Abstract] [Full Text] [Related]
20. Analysis of nodal coverage utilizing image guided radiation therapy for primary gynecologic tumor volumes. Ahmed F, Sarkar V, Gaffney DK, Salter B, Poppe MM. Med Dosim; 2016 Feb 15; 41(3):195-8. PubMed ID: 26994828 [Abstract] [Full Text] [Related] Page: [Next] [New Search]